Cocrystal Pharma Inc. is a biotechnology company focused on the development of innovative antiviral therapies to treat various viral infections
The company utilizes its proprietary drug discovery platform to create novel compounds aimed at inhibiting viral replication and targeting specific viral targets. Cocrystal Pharma is particularly engaged in research related to hepatitis and influenza, striving to address unmet medical needs in the field of infectious diseases. Through its scientific advancements and strategic partnerships, the company aims to deliver effective treatments that can significantly improve patient outcomes.
The Dow Jones closed slightly higher on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Gainers Inpixon (NASDAQ: INPX) shares rose 41% to $2.20 in pre-market trading after gaining 6% on Tuesday. Inpixon, last month, secured a purchase order valued at over $1m for its RTLS products from a leading transportation and industrial equipment provider.
